Low doses of arginine butyrate derivatives improve dystrophic phenotype and restore membrane integrity in DMD models-Reference-Cited by-同舟云学术

Low doses of arginine butyrate derivatives improve dystrophic phenotype and restore membrane integrity in DMD models

Published:2014-03-06 Issue:6 Volume:28 Page:2603-2619
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Vianello Sara¹,Consolaro Francesca¹,Bich Claudia²,Cancela José‐Manuel³,Roulot Morgane¹,Lanchec Erwan³,Touboul David²,Brunelle Alain²,Israël Maurice¹,Benoit Evelyne¹,Porte Sabine¹

Affiliation:

1. Neurobiologie and DéveloppementInstitut de Neurobiologie Alfred Fessard–Fédération pour la Recherche sur le Cerveau (FRC) 2118Unité Propres de Recherche (UPR) 3294Centre National de la Recherche Scientifique (CNRS)Gif sur YvetteFrance

2. Institut de Chimie des Substances NaturellesCentre de Recherche de Gif, UPR 2301Centre National de la Recherche Scientifique (CNRS)Gif sur YvetteFrance

3. Centre de Neurosciences Paris‐SudUniversité Paris SudUnité Mixte de Recherche (UMR) 8195, CNRSOrsayFrance

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.13-244798

Reference36 articles.

1. Function and Genetics of Dystrophin and Dystrophin-Related Proteins in Muscle

2. Read-Through Strategies for Suppression of Nonsense Mutations in Duchenne/ Becker Muscular Dystrophy: Aminoglycosides and Ataluren (PTC124)

3. Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy

4. Stem Cell Therapies to Treat Muscular Dystrophy

5. Current Status of Pharmaceutical and Genetic Therapeutic Approaches to Treat DMD

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients;Trends in Molecular Medicine;2024-03

2. Valproic acid reduces muscle susceptibility to contraction‐induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy;Clinical and Experimental Pharmacology and Physiology;2023-06-29

3. CD38‐NADase is a new major contributor to Duchenne muscular dystrophic phenotype;EMBO Molecular Medicine;2022-03-17

4. A Long-Term Study Evaluating the Effects of Nicorandil Treatment on Duchenne Muscular Dystrophy-Associated Cardiomyopathy in mdx Mice;Journal of Cardiovascular Pharmacology and Therapeutics;2022-01-01

5. Regenerative Rehabilitation for Duchenne Muscular Dystrophy;Physiology in Health and Disease;2022